Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This reflects a small site update that changes the page version label but does not alter the study details or their presentation.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a recent build or deployment of the page.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision has been updated to v3.6.3, indicating a new version of the ClinicalTrials.gov entry. This metadata change does not alter the displayed study details or results.SummaryDifference0.1%

- Check84 days agoChange DetectedThe footer revision tag has been updated to v3.6.2, representing a small page-version update with no changes to the study information.SummaryDifference0.1%

- Check98 days agoChange DetectedRecruitment status updated to indicate no participants are being sought. New Help/How-To sections were added, the Intervention/Treatment header was standardized, and the page revision was updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.